FR2199988A1 - - Google Patents

Info

Publication number
FR2199988A1
FR2199988A1 FR7333497A FR7333497A FR2199988A1 FR 2199988 A1 FR2199988 A1 FR 2199988A1 FR 7333497 A FR7333497 A FR 7333497A FR 7333497 A FR7333497 A FR 7333497A FR 2199988 A1 FR2199988 A1 FR 2199988A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7333497A
Other languages
French (fr)
Other versions
FR2199988B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHRISTIAENS MANUF PROD PHARMA
Original Assignee
CHRISTIAENS MANUF PROD PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHRISTIAENS MANUF PROD PHARMA filed Critical CHRISTIAENS MANUF PROD PHARMA
Publication of FR2199988A1 publication Critical patent/FR2199988A1/fr
Application granted granted Critical
Publication of FR2199988B1 publication Critical patent/FR2199988B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7333497A 1972-09-18 1973-09-18 Expired FR2199988B1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB4315072 1972-09-18
GB998773*[A GB1405444A (en) 1972-09-18 1973-03-01 2-aminoindane derivatives
GB998873 1973-03-01
GB1030373 1973-03-02

Publications (2)

Publication Number Publication Date
FR2199988A1 true FR2199988A1 (de) 1974-04-19
FR2199988B1 FR2199988B1 (de) 1977-11-25

Family

ID=27447738

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7333497A Expired FR2199988B1 (de) 1972-09-18 1973-09-18

Country Status (13)

Country Link
JP (1) JPS5327263B2 (de)
AR (4) AR206505A1 (de)
CA (1) CA992547A (de)
CH (1) CH585690A5 (de)
DD (2) DD109802A5 (de)
ES (3) ES418827A1 (de)
FR (1) FR2199988B1 (de)
GB (1) GB1405444A (de)
HU (1) HU168018B (de)
IL (1) IL43218A (de)
LU (1) LU68426A1 (de)
MX (1) MX3233E (de)
NL (1) NL152246B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975461A (en) * 1986-06-19 1990-12-04 E. R. Squibb & Sons, Inc. P-aminophenols, derivatives thereof and method of use
JPH0293610U (de) * 1989-01-09 1990-07-25
AU777517B2 (en) * 1999-06-10 2004-10-21 Bridge Pharma, Inc. Dermal anesthetic agents
EP1658847A3 (de) * 1999-06-10 2006-07-26 Bridge Pharma, Inc. Indanderivate als dermale Anästhetika
CA2350992C (en) 1999-09-17 2009-06-23 Suntory Limited Preventive or therapeutic agents for myocarditis, dilated cardiomyopathy and heart failure comprising nf-kb inhibitors as active ingredients
US20010018446A1 (en) 1999-09-23 2001-08-30 G.D. Searle & Co. Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
WO2006036936A2 (en) 2004-09-27 2006-04-06 Bridge Pharma, Inc. The s-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
CA2655809C (en) 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds

Also Published As

Publication number Publication date
LU68426A1 (de) 1973-11-26
CA992547A (en) 1976-07-06
DD108277A5 (de) 1974-09-12
DE2346337B2 (de) 1976-08-26
JPS5327263B2 (de) 1978-08-07
NL7312776A (de) 1974-03-20
FR2199988B1 (de) 1977-11-25
IL43218A (en) 1977-05-31
AR205891A1 (es) 1976-06-15
ES440030A1 (es) 1977-02-16
AU6028373A (en) 1975-03-13
GB1405444A (en) 1975-09-10
DD109802A5 (de) 1974-11-20
JPS4969648A (de) 1974-07-05
HU168018B (de) 1976-02-28
MX3233E (es) 1980-08-05
ES440029A1 (es) 1977-02-16
NL152246B (nl) 1977-02-15
IL43218A0 (en) 1973-11-28
AR204247A1 (es) 1975-12-10
DE2346337A1 (de) 1974-04-04
AR206505A1 (es) 1976-07-30
AR203500A1 (es) 1975-09-15
CH585690A5 (de) 1977-03-15
ES418827A1 (es) 1977-02-01

Similar Documents

Publication Publication Date Title
JPS4999802A (de)
FR2199988B1 (de)
JPS4968135A (de)
JPS4984772A (de)
JPS4895007A (de)
JPS4986266A (de)
CH583524A5 (de)
CH563689A5 (de)
CH576845A5 (de)
CH153673A4 (de)
CH284873A4 (de)
BG21861A3 (de)
CH559258A (de)
CH561420A5 (de)
CH561884A5 (de)
CH562345A5 (de)
CH563639A5 (de)
CH578036A5 (de)
BG20394A3 (de)
CH563641A5 (de)
BG19364A3 (de)
BG19033A1 (de)
BG22788A3 (de)
CH583690A5 (de)
CH577134A5 (de)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse